Health ❯ Obesity

Weight Loss

Medications Pharmaceuticals Pharmaceutical Treatments Bariatric Surgery Medication GLP-1 Drugs Clinical Trials Surgery GLP-1 Medications Medical Treatments

Tirzepatide Raises Imaging Signals of Brown Adipose Tissue in Small Randomized Trial

This could mean the drug raises calorie burning at the tissue level; confirmation will require larger trials and tissue analysis.

Penn Study Finds About 30% Lower Breast Cancer Rates Associated With GLP‑1 Use

AHA Says Exercise Should Be Prescribed as Core Part of Obesity Care

Semaglutide Causes Weight Loss by Raising cAMP in Hindbrain Neurons, NIH Study Finds

Weight-Loss Jabs Linked to Halved Sick Days and Fewer NHS Visits, Real-World Study Finds

8,500 Daily Steps Tied to Keeping Weight Off, Meta-Analysis Finds

Study Finds 8,500 Daily Steps Help People Keep Weight Off After Dieting

Tirzepatide Linked to Lower Death and Heart Events After PCI and TAVR in New Real-World Analyses

GLP-1 Weight-Loss Draws Harsher Stigma Than Lifestyle Change, Study Finds

AI Review of 400,000 Reddit Posts Flags Possible GLP-1 Side Effects Beyond the Gut

Mexico Renews Warning as Counterfeit GLP-1 Weight-Loss Drugs Spread Worldwide

Semaglutide Patent Expires in Brazil, Opening Door to Lower-Cost Rivals

Zealand Plunges as Roche Obesity Drug Posts 10.7% Weight Loss With Placebo‑Like Tolerability

After Stopping GLP-1 Weight-Loss Drugs, Most Lost Weight Returns Within a Year, Analysis Finds

German Endocrinologist Calls for Statutory Coverage of Weight-Loss Injections as Illegal Procurement Rises

Restricting Two Amino Acids Triggers Beige Fat Thermogenesis in Mice

Novo’s Triple-Hormone Obesity Drug UBT251 Hits 19.7% Mean Weight Loss in China Phase 2

Private GLP-1 Weight-Loss Use in UK Skews to Middle-Class Women, Analysis Shows

GLP-1 Boom Rewrites Menus as McDonald's Tests Protein-Forward Options

Eli Lilly Builds $1.5 Billion Stockpile of Orforglipron as FDA Decision Nears